Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
IM Cannabis Corp
(CSE:
IMCC
)
3.500
-0.240 (-6.42%)
Official Closing Price
Updated: 1:17 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about IM Cannabis Corp
IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3
November 14, 2024
International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue...
Via
Benzinga
Topics
Cannabis
Economy
Exposures
Cannabis
Supply Chain
Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?
November 06, 2024
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE:...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About
October 10, 2024
The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York's chief equity...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
October 04, 2024
Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
October 02, 2024
Spain's Ministry of Health revealed this week a draft royal decree for public consultation, outlining the suggested regulations for prescribing cannabis-based medications, reported Business of...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
August 14, 2024
The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023....
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
August 06, 2024
Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know
July 05, 2024
IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany
June 05, 2024
Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue
May 08, 2024
IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decrease compared to the same quarter...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
March 28, 2024
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
August 14, 2023
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Tuesday for the period ending June 30, 2023.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
December 01, 2021
IM Cannabis Corp. (CSE:IMCC), (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval
November 30, 2021
IM Cannabis Corp. (CSE:IMCC) (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.